Health Canada, CADTH, and Quebec’s l’Institut national d’excellence en santé et en services sociaux (INESSS) have scheduled a webinar to detail their new aligned review process and to answer any questions stakeholders may have about the initiative.
As announced in June 2018, Health Canada, CADTH, and INESSS are increasing their efforts to align drug reviews in order to support the affordability, accessibility, and appropriate use of prescription drugs in Canada.
As part of Health Canada’s Regulatory Review of Drugs and Devices initiative, drug manufacturers now have the option to participate in a formalized, aligned review process for all submissions that qualify, including new drugs and drugs for new indications.
This webinar is meant for anyone interested in learning more about this process.
Registration is required for this webinar.
To participate, please send your name and email address to email@example.com. Participants will receive a confirmation email containing log-in information and an agenda.
Interested parties may send questions in advance to the above-mentioned email to be answered by Health Canada, CADTH, and INESSS during the session. Questions will also be taken during the session.